Screening for CMV in Pregnancy

     

The National Institute for Clinical Excellence (NICE) currently do not recommend routine antenatal screening for CMV. This because there is currently no way of preventing transmission of the virus to an unborn baby and no way to determine whether a baby will be born with problems.

A study in the US is testing whether CMV Immunoglobulin therapy may reduce the risk of transmission when given to pregnant women experiencing a primary CMV infection. This follows mixed results from previous studies of immunoglobulin therapy in Italy.  The US study is due to report in 2019.

In the meantime, CMV Action is working with researchers to try and secure funding for a pilot to test out how CMV screening in pregnancy could work within the NHS.

We will continue to campaign for change.

 

     

Our Stories

Noah was born on 30th January 2009 after a fairly unremarkable pregnancy and a fairly normal delivery (even with the cord round his neck!) He failed his newborn hearing screening test... Read more
Four weeks before the due date of our second child, Mylo, a breech scan showed he had excessive fluid on his brain and his weight had dropped dramatically from previous growth... Read more

Latest Events

Thursday 28 February

Registered charity no: 1171773